Concepedia

Mary Jo Gleason

MJ

Statistics

Publications

12

Citations

1.8K

H-Index

12

Active since

1991

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, San Francisco

Mary Jo Gleason is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and glioma chemotherapy.

Publications per year

1991–2003

12

Publications

12

Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials

Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason et al. · Journal of Clinical Oncology · 1999 · 901 citations

Medicine, Oncology, Surgery +17

Intravenous carboplatin for recurrent malignant glioma: a phase II study.

W.K. Alfred Yung, László Mechtler, Mary Jo Gleason · Journal of Clinical Oncology · 1991 · 179 citations

Medicine, Oncology, Pharmacology +17

Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.

W. K. Alfred Yung, Athanassios P. Kyritsis, Mary Jo Gleason et al. · PubMed · 1996 · 122 citations

Medicine, Oncology, Pharmacology +16

Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.

Victor A. Levin, Kenneth R. Hess, Ali Choucair et al. · PubMed · 2003 · 114 citations

Medicine, Pharmacotherapy, Radiation Oncology +16

The Treatment of Anaplastic Oligodendrogliomas and Mixed Gliomas

Athanassios P. Kyritsis, W.K. Alfred Yung, Janet Bruner et al. · Neurosurgery · 1993 · 96 citations

Medicine, Oncology, Chemotherapy +15

1–5 of 12